Our finding suggested that this phenomenon occurred through an activation of TGFβ to reduce proinflammatory and cytokine gene signatures such as CCL8, CCL11, CXCL10, and TNFSF12 leading to immune suppression in patients with CRC. The gene discussed is CCL11; the disease is colorectal carcinoma.